Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

A month has gone by since the last earnings report for Nevro (NVRO). Shares have added about 15.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Nevro is advancing its application to the FDA for its spinal cord stimulation treatment of PDN with a potential launch later this year. Nevro is guiding for a strong recovery in 2021, which is ...

Nevro Corp. NVRO reported a loss per share of 70 cents in the first quarter of 2024 compared with the year-ago quarter’s loss of 98 cents. The metric beat the Zacks Consensus Estimate by 31.37%.

The market expects Nevro (NVRO) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2020. This widely-known consensus outlook is ...

Analysts' ratings for Nevro (NYSE:NVRO) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below offers a condensed view of their recent ratings, showcasing ...